Core Lab Reports Second Quarter 2020 Results From Continuing Operations:
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Core Laboratories (CLB) PT Raised to $26 at Cowen
July 24, 2020 8:06 AM EDTCowen analyst Marc Bianchi raised the price target on Core Laboratories (NYSE: CLB) to $26.00 (from $24.00) while maintaining a Market Perform rating.
... MoreCore Laboratories (CLB) PT Raised to $27 at RBC Capital
July 23, 2020 1:58 PM EDTRBC Capital analyst Kurt Hallead raised the price target on Core Laboratories (NYSE: CLB) to $27.00 (from $24.00) while maintaining an Outperform rating.
The analyst commented, "CLB continues to adhere to its long standing financial tenets of maximizing FCF, ROIC and returning excess... More
Core Laboratories (CLB) Tops Q2 EPS by 4c
July 22, 2020 5:16 PM EDTCore Laboratories (NYSE: CLB) reported Q2 EPS of $0.14, $0.04 better than the analyst estimate of $0.10. Revenue for the quarter came in at $115.7 million versus the consensus estimate of $115.35 million.
Industry and Core Lab Outlook:
Although crude-oil prices improved from the lows seen in May, E&P companies further reduced their 2020 capital expenditure plans, especially in... More
